Aurinia Pharmaceuticals (AUPH) EPS (Diluted) Growth (1y) (2021 - 2026)
Aurinia Pharmaceuticals (AUPH) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 8.02% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -4.52% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 96.09% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 144.25% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -99.90% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -11.18% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 315.14% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 96.41% |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 78.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.98% |
| Mar 31, 2026 | 53.11% |
| Dec 31, 2025 | 14,942.87% |
| Sep 30, 2025 | 136.25% |
| Jun 30, 2025 | 3,028.53% |
| Mar 31, 2025 | 319.20% |
| Dec 31, 2024 | 105.39% |
| Sep 30, 2024 | 204.33% |
| Jun 30, 2024 | 106.22% |
| Mar 31, 2024 | 59.52% |
| Dec 31, 2023 | -2.31% |
| Sep 30, 2023 | -48.58% |
| Jun 30, 2023 | 67.88% |
| Mar 31, 2023 | 30.83% |
| Dec 31, 2022 | 28.82% |
| Sep 30, 2022 | 83.80% |
| Jun 30, 2022 | 31.65% |
| Mar 31, 2022 | 32.83% |
| Dec 31, 2021 | -277.95% |
| Sep 30, 2021 | -13.63% |